Additionally, since we previously suggested the possible implication of hepatic OLFM2 in NAFLD progression, now we propose a possible interaction between the liver and SAT, reinforcing the potential implication of this tissue in NAFLD development. Here, OLFM2 is linked to metabolic dysfunction-associated steatotic liver disease.